Randomized Withdrawal Study in Patients With Schizophrenia
NCT06961968
This study is recruiting at 22 US sites in 12 states, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this research is to evaluate the efficacy of dosing iloperidone long-acting injection (LAI) compared to placebo in preventing the exacerbation of symptoms in patients with schizophrenia.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Schizophrenia
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 3
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Vanda Pharmaceuticals
- Last updated on ClinicalTrials.gov
- January 12, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Arkansas · 1
- Vanda Investigational Site · Rogers, AR
California · 6
- Vanda Investigational Site · Costa Mesa, CA
- Vanda Investigational Site · Lemon Grove, CA
- Vanda Investigational Site · Oceanside, CA
- Vanda Investigational Site · Pico Rivera, CA
- Vanda Investigational Site · San Diego, CA
- Vanda Investigational Site · Walnut Creek, CA
Florida · 1
- Vanda Investigational Site · North Miami, FL
Georgia · 2
- Vanda Investigational Site · Atlanta, GA
- Vanda Investigational Site · Peachtree Corners, GA
Illinois · 1
- Vanda Investigational Site · Chicago, IL
Mississippi · 1
- Vanda Investigational Site · Flowood, MS
Missouri · 2
- Vanda Investigational Site · Saint Charles, MO
- Vanda Investigational Site · St Louis, MO
Nevada · 1
- Vanda Investigational Site · Las Vegas, NV
New Jersey · 1
- Vanda Investigational Site · Marlton, NJ
New York · 1
- Vanda Investigational Site · Staten Island, NY
Texas · 4
- Vanda Investigational Site · Austin, TX
- Vanda Investigational Site · Houston, TX
- Vanda Investigational Site · Irving, TX
- Vanda Investigational Site · Richardson, TX
Washington · 1
- Vanda Investigational Site · Bellevue, WA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.